This review summarises and discusses the methods and results of the Randomised Evaluation of Dual Antithrombotic Therapy with Dabigatran after percutaneous coronary intervention (PCI) in Atrial Fibrillation (the RE-DUAL PCI) study.
Independent expert commentary provided by Dr Allison Morton, a cardiologist specialist at HeartCare Bunbury, WA.
Please login below to download this issue (PDF)